Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Nilemdo and Nustendi

April 7, 2020

Millendo Therapeutics discontinues development of livoletide for PWS

April 7, 2020

Opaganib approved for compassionate use in patients with COVID-19 in Italy

April 7, 2020

First patient dosed in phase I study of COM-902 in advanced malignancies

April 7, 2020

Glycoprotein negatively regulates adult neurogenesis

April 7, 2020

Ennaid begins development of ENU-200 for COVID-19 infection

April 7, 2020

GRASP55 plays a key physiological role in intestinal lipid uptake

April 7, 2020

Large-scale proteomic analysis unveils a shift in glutaminate fate involved in cancer progression

April 7, 2020

Head and neck cancer cachexia mouse model developed

April 7, 2020

The dose makes the poison -- timing, too

April 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...